Tetrahydrobiopterin causes mitochondrial dysfunction in dopaminergic cells: Implications for Parkinson's disease
- 1 March 2006
- journal article
- Published by Elsevier in Neurochemistry International
- Vol. 48 (4) , 255-262
- https://doi.org/10.1016/j.neuint.2005.10.011
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Dopamine‐dependent cytotoxicity of tetrahydrobiopterin: a possible mechanism for selective neurodegeneration in Parkinson's diseaseJournal of Neurochemistry, 2003
- Involvement of apoptosis and calcium mobilization in tetrahydrobiopterin-induced dopaminergic cell deathExperimental Neurology, 2003
- Mitochondria, Oxidative Damage, and Inflammation in Parkinson's DiseaseAnnals of the New York Academy of Sciences, 2003
- Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stressPharmacology & Therapeutics, 2003
- Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson’s diseaseNeurotoxicity Research, 2003
- Tetrahydrobiopterin Enhances Apoptotic PC12 Cell Death following Withdrawal of Trophic SupportPublished by Elsevier ,2001
- Chronic systemic pesticide exposure reproduces features of Parkinson's diseaseNature Neuroscience, 2000
- Tetrahydrobiopterin Is Released from and Causes Preferential Death of Catecholaminergic Cells by Oxidative StressMolecular Pharmacology, 2000
- Dopamine Oxidation Alters Mitochondrial Respiration and Induces Permeability Transition in Brain MitochondriaJournal of Neurochemistry, 1999
- Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromesBrain, 1993